Article Id:JPRS-P col-00003040 Title:The epidermal growth factor receptor as target for cancer therapy Category:Pharmaceutics Section:Review Article
Abstract
Audio Abstract
Authors
Pdf File
Citation
My Reference
Methodology
Abstract
Human carcinomas express high levels of receptors in the epidermal growth factor (EGF) receptor family, it includes two important EGF receptors; they are EGF receptor (EGFR) and ErbB2. Function of these receptors is more useful for anticancer treatments. The monoclonal antibodies (MAbs) block the activation of EGFR and ErbB2. A humanized anti-ErbB2 is active and recently approved in combination with paclitaxel for the therapy of patients with metastatic ErbB2 over aggressive breast cancer, a chimeric anti-EGFR MAb is active in combination with radiation therapy and reverses resistance to chemotherapy.
Abstract Audio
No Audio file found
About the authors and Affiliations
Name
JPR Solutions
Author(s) Name:
M. Indhumathi 1 , M. P. Brundha1 , Hemavathy O. R2*
Affiliation(s) Name:
1 Department of General Pathology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India,
2 Department of Oral and Maxillofacial Surgery, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India
*Corresponding author: O.R. Hemavathy, Department of Oral and Maxillofacial Surgery, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, 162, Poonamallee High Road, Chennai - 600077, Tamil Nadu, India